|
RWDD2B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.437800E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.023600E-01 |
| Normal-vs-Stage2 |
5.999200E-01 |
| Normal-vs-Stage3 |
3.548400E-02 |
| Normal-vs-Stage4 |
3.739500E-02 |
| Stage1-vs-Stage2 |
1.533370E-01 |
| Stage1-vs-Stage3 |
6.769800E-02 |
| Stage1-vs-Stage4 |
1.431390E-01 |
| Stage2-vs-Stage3 |
1.679890E-02 |
| Stage2-vs-Stage4 |
3.117600E-02 |
| Stage3-vs-Stage4 |
9.644600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.878200E-02 |
| Normal-vs-AfricanAmerican |
5.660400E-01 |
| Normal-vs-Asian |
4.274200E-01 |
| Caucasian-vs-AfricanAmerican |
4.624200E-01 |
| Caucasian-vs-Asian |
3.690800E-01 |
| AfricanAmerican-vs-Asian |
9.488800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.453200E-01 |
| Normal-vs-Female |
9.407700E-02 |
| Male-vs-Female |
4.895500E-03 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.918640E-01 |
| Normal-vs-Age(41-60Yrs) |
3.283400E-01 |
| Normal-vs-Age(61-80Yrs) |
3.404800E-01 |
| Normal-vs-Age(81-100Yrs) |
2.756000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.383200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.652200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.536200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.280000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.838400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.312400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.177800E-01 |
| Classical-VS-Follicular |
9.441700E-04 |
| Classical-VS-Other |
6.367000E-01 |
| Classical-VS-Normal |
8.613600E-02 |
| Tall-VS-Follicular |
1.134190E-02 |
| Tall-VS-Other |
4.409600E-01 |
| Tall-VS-Normal |
6.395600E-02 |
| Follicular-VS-Other |
4.951600E-01 |
| Follicular-VS-Normal |
2.155000E-01 |
| Other-VS-Normal |
8.096800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.449800E-01 |
| Normal-vs-N1 |
1.137230E-03 |
| N0-vs-N1 |
2.683000E-03 |
|
|
